Camp4 Therapeutics grants 39,000 inducement stock options at $3.96 per share

CAMP4 Therapeutics Corporation

CAMP4 Therapeutics Corporation

CAMP

0.00
  • Camp4 Therapeutics granted non-qualified stock options covering 39,000 shares to three newly hired employees on June 15, 2026.
  • Options carry a 10-year term with an exercise price of USD 3.96 per share, matching the stock’s closing price on the grant date.
  • Awards vest over four years: 25% after one year, then the balance in 36 equal monthly installments, subject to continued service.
  • Grants were issued under the company’s 2026 Inducement Plan.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Camp4 Therapeutics Corporation published the original content used to generate this news brief on June 19, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.